LT2897611T - Hepatito c gydymo būdai - Google Patents

Hepatito c gydymo būdai

Info

Publication number: LT2897611T
Authority: LT; Lithuania
Prior art keywords: methods; treating hepatitis; hepatitis; treating
Prior art date: 2012-09-18

Application number

LT13773463T

Other languages

English (en)

Inventor

Teresa Ng (lok-Chan)

Tami J Pilot-Matias

Warren M Kati

Preethi Krishnan

Clarence J Maring

Neeta C Mistry

Thomas J Reisch

Rolf Wagner

Dachun Liu

John K Pratt

Mark A Matulenko

Ryan G Keddy

Original Assignee

Abbvie Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-18

Filing date

2013-09-17

Publication date

2019-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49304326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2897611(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-09-17 Application filed by Abbvie Inc filed Critical Abbvie Inc

2019-12-10 Publication of LT2897611T publication Critical patent/LT2897611T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

LT13773463T 2012-09-18 2013-09-17 Hepatito c gydymo būdai LT2897611T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261702564P	2012-09-18	2012-09-18
PCT/US2013/060103 WO2014047039A1 (en)	2012-09-18	2013-09-17	Methods for treating hepatitis c

Publications (1)

Publication Number	Publication Date
LT2897611T true LT2897611T (lt)	2019-12-10

Family

ID=49304326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LT13773463T LT2897611T (lt)	2012-09-18	2013-09-17	Hepatito c gydymo būdai

Country Status (25)

Country	Link
US (1)	US20140080868A1 (lt)
EP (2)	EP3597190A1 (lt)
JP (4)	JP6297044B2 (lt)
CN (1)	CN104797253A (lt)
AU (2)	AU2013318302B2 (lt)
BR (1)	BR112015006037B1 (lt)
CA (1)	CA2884539C (lt)
CY (1)	CY1122442T1 (lt)
DK (1)	DK2897611T3 (lt)
ES (1)	ES2755089T3 (lt)
HK (1)	HK1209319A1 (lt)
HR (1)	HRP20191939T1 (lt)
HU (1)	HUE046544T2 (lt)
LT (1)	LT2897611T (lt)
MX (2)	MX367796B (lt)
NZ (1)	NZ630581A (lt)
PL (1)	PL2897611T3 (lt)
PT (1)	PT2897611T (lt)
RS (1)	RS59640B1 (lt)
RU (1)	RU2665365C2 (lt)
SG (2)	SG10201702248UA (lt)
SI (1)	SI2897611T1 (lt)
TW (1)	TWI621436B (lt)
WO (1)	WO2014047039A1 (lt)
ZA (1)	ZA201501752B (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE046544T2 (hu) *	2012-09-18	2020-03-30	Abbvie Inc	Eljárások Hepatitis C kezelésére
TWI642436B (zh) *	2013-03-14	2018-12-01	艾伯維有限公司	治療ｈｃｖ的方法
US11484534B2 (en)	2013-03-14	2022-11-01	Abbvie Inc.	Methods for treating HCV
AU2015240753B2 (en) *	2014-04-02	2020-01-16	Abbvie Inc.	Methods for treating HCV
EP3125889A1 (en)	2014-04-02	2017-02-08	AbbVie Inc.	Methods for treating hcv
US20160375017A1 (en)	2015-06-26	2016-12-29	Abbvie Inc.	Solid Pharmaceutical Compositions for Treating HCV
WO2016210273A1 (en) *	2015-06-26	2016-12-29	Abbvie Inc.	Solid pharmaceutical compositions for treating hcv
MX2018000240A (es) *	2015-07-08	2018-03-14	Abbvie Inc	Metodos para tratar el vhc.
JP7133466B2 (ja) *	2015-07-17	2022-09-08	アッヴィ・インコーポレイテッド	Ｈｃｖを処置するための固体医薬組成物
EP3448392A4 (en)	2016-04-28	2020-01-15	Emory University	ALCYNE-CONTAINING NUCLEOTIDES AND NUCLEOSIDES THERAPEUTIC COMPOSITIONS AND USES THEREOF
US20220175812A1 (en)	2020-12-03	2022-06-09	Battelle Memorial Institute	Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (ja)	2021-04-07	2024-04-12	バテル・メモリアル・インスティテュート	非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
GB202113944D0 (en) *	2021-09-29	2021-11-10	Univ Liverpool	Injectable formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20080197A1 (es) *	2006-02-09	2008-04-11	Schering Corp	Combinaciones que involucran el (los) inhibidor (es) de la proteasa del hcv, y metodos de tratamiento relacionado al (los) mismos(s)
AR075584A1 (es) *	2009-02-27	2011-04-20	Intermune Inc	COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
US9394279B2 (en) *	2009-06-11	2016-07-19	Abbvie Inc.	Anti-viral compounds
US8937150B2 (en) *	2009-06-11	2015-01-20	Abbvie Inc.	Anti-viral compounds
DE112012003457T5 (de) *	2011-10-21	2015-03-12	Abbvie Inc.	Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV)
HUE046544T2 (hu) *	2012-09-18	2020-03-30	Abbvie Inc	Eljárások Hepatitis C kezelésére

2013
- 2013-09-17 HU HUE13773463A patent/HUE046544T2/hu unknown
- 2013-09-17 MX MX2015003501A patent/MX367796B/es active IP Right Grant
- 2013-09-17 CA CA2884539A patent/CA2884539C/en active Active
- 2013-09-17 LT LT13773463T patent/LT2897611T/lt unknown
- 2013-09-17 NZ NZ630581A patent/NZ630581A/en unknown
- 2013-09-17 WO PCT/US2013/060103 patent/WO2014047039A1/en active Application Filing
- 2013-09-17 BR BR112015006037-4A patent/BR112015006037B1/pt active IP Right Grant
- 2013-09-17 PT PT137734638T patent/PT2897611T/pt unknown
- 2013-09-17 SG SG10201702248UA patent/SG10201702248UA/en unknown
- 2013-09-17 SI SI201331607T patent/SI2897611T1/sl unknown
- 2013-09-17 EP EP19187747.1A patent/EP3597190A1/en active Pending
- 2013-09-17 EP EP13773463.8A patent/EP2897611B1/en active Active
- 2013-09-17 RU RU2015114543A patent/RU2665365C2/ru active
- 2013-09-17 CN CN201380060100.7A patent/CN104797253A/zh active Pending
- 2013-09-17 RS RS20191378A patent/RS59640B1/sr unknown
- 2013-09-17 DK DK13773463T patent/DK2897611T3/da active
- 2013-09-17 PL PL13773463T patent/PL2897611T3/pl unknown
- 2013-09-17 AU AU2013318302A patent/AU2013318302B2/en active Active
- 2013-09-17 SG SG11201502095SA patent/SG11201502095SA/en unknown
- 2013-09-17 US US14/029,302 patent/US20140080868A1/en not_active Abandoned
- 2013-09-17 ES ES13773463T patent/ES2755089T3/es active Active
- 2013-09-17 JP JP2015532139A patent/JP6297044B2/ja active Active
- 2013-09-18 TW TW102133969A patent/TWI621436B/zh active
2015
- 2015-03-13 ZA ZA2015/01752A patent/ZA201501752B/en unknown
- 2015-03-18 MX MX2019010600A patent/MX2019010600A/es unknown
- 2015-10-13 HK HK15109967.3A patent/HK1209319A1/xx unknown
2018
- 2018-02-19 JP JP2018026645A patent/JP6556884B2/ja active Active
- 2018-05-22 AU AU2018203608A patent/AU2018203608B2/en active Active
2019
- 2019-07-11 JP JP2019128933A patent/JP2019194241A/ja active Pending
- 2019-10-24 CY CY20191101109T patent/CY1122442T1/el unknown
- 2019-10-24 HR HRP20191939TT patent/HRP20191939T1/hr unknown
2020
- 2020-12-21 JP JP2020211042A patent/JP2021054849A/ja active Pending

Also Published As

Publication number	Publication date
WO2014047039A1 (en)	2014-03-27
EP3597190A1 (en)	2020-01-22
AU2013318302B2 (en)	2018-02-22
MX2015003501A (es)	2015-10-26
JP2015528511A (ja)	2015-09-28
HUE046544T2 (hu)	2020-03-30
AU2018203608B2 (en)	2019-12-19
JP6297044B2 (ja)	2018-03-20
PL2897611T3 (pl)	2020-03-31
HRP20191939T1 (hr)	2020-01-10
CY1122442T1 (el)	2021-01-27
SG10201702248UA (en)	2017-04-27
DK2897611T3 (da)	2019-11-04
TW201412311A (zh)	2014-04-01
EP2897611B1 (en)	2019-07-24
AU2013318302A1 (en)	2015-04-02
MX2019010600A (es)	2020-02-03
HK1209319A1 (en)	2016-04-01
CA2884539A1 (en)	2014-03-27
NZ630581A (en)	2017-02-24
JP2021054849A (ja)	2021-04-08
RS59640B1 (sr)	2020-01-31
JP6556884B2 (ja)	2019-08-07
JP2019194241A (ja)	2019-11-07
BR112015006037A2 (pt)	2017-07-04
ZA201501752B (en)	2016-08-31
SI2897611T1 (sl)	2019-12-31
ES2755089T3 (es)	2020-04-21
CN104797253A (zh)	2015-07-22
RU2015114543A (ru)	2016-11-10
TWI621436B (zh)	2018-04-21
RU2665365C2 (ru)	2018-08-29
SG11201502095SA (en)	2015-05-28
AU2018203608A1 (en)	2018-06-14
US20140080868A1 (en)	2014-03-20
BR112015006037B1 (pt)	2022-05-17
JP2018109035A (ja)	2018-07-12
EP2897611A1 (en)	2015-07-29
CA2884539C (en)	2022-06-21
MX367796B (es)	2019-09-06
PT2897611T (pt)	2019-11-27

Publication	Publication Date	Title
HRP20180237T1 (hr)	2018-03-09	Metode za liječenje hcv-a
HK1214504A1 (zh)	2016-07-29	用於治療貧血的方法
HK1209745A1 (en)	2016-04-08	Compounds and methods for antiviral treatment
HK1209319A1 (en)	2016-04-01	Methods for treating hepatitis c
EP2757887A4 (en)	2015-05-27	PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV
HK1198869A1 (en)	2015-06-19	Combination treatments for hepatitis c
ZA201906339B (en)	2021-07-28	Methods for treating pruritus
HK1209320A1 (en)	2016-04-01	Methods for treating hepatitis c
ZA201406172B (en)	2016-05-25	Compounds and methods for treating leukemia
HK1209040A1 (en)	2016-03-24	Methods for treating vestibulotoxicity
EP2854774A4 (en)	2015-11-18	METHODS OF TREATING INSOMNIA
GB201214387D0 (en)	2012-09-26	Methods for treating plants
GB201209932D0 (en)	2012-07-18	Improved process